Fosfolipasas A2: Grandes familias y mecanismos de acción

Autores:: García, Gregory Alfonso
García Cardona, Ananías

Tipo de recurso:: Article of journal

Fecha de publicación:: 2009

Institución:: Fundación Universitaria de Ciencias de la Salud - FUCS

Repositorio:: Repositorio Digital Institucional ReDi

Idioma:: spa

id	FUCS2_530623e08dd38af447e07cd26b0ccaad
oai_identifier_str	oai:repositorio.fucsalud.edu.co:001/2449
network_acronym_str	FUCS2
network_name_str	Repositorio Digital Institucional ReDi
repository_id_str
dc.title.spa.fl_str_mv	Fosfolipasas A2: Grandes familias y mecanismos de acción
dc.title.translated.eng.fl_str_mv	Phospholipases A2: Large families and mechanisms of action
title	Fosfolipasas A2: Grandes familias y mecanismos de acción
spellingShingle	Fosfolipasas A2: Grandes familias y mecanismos de acción bioquímico enzimología genética fosfolipasa AZ (PLA2) biochemistry enzymology genetics phospholipase AZ (PLA2)
title_short	Fosfolipasas A2: Grandes familias y mecanismos de acción
title_full	Fosfolipasas A2: Grandes familias y mecanismos de acción
title_fullStr	Fosfolipasas A2: Grandes familias y mecanismos de acción
title_full_unstemmed	Fosfolipasas A2: Grandes familias y mecanismos de acción
title_sort	Fosfolipasas A2: Grandes familias y mecanismos de acción
dc.creator.fl_str_mv	García, Gregory Alfonso García Cardona, Ananías
dc.contributor.author.spa.fl_str_mv	García, Gregory Alfonso García Cardona, Ananías
dc.subject.spa.fl_str_mv	bioquímico enzimología genética fosfolipasa AZ (PLA2)
topic	bioquímico enzimología genética fosfolipasa AZ (PLA2) biochemistry enzymology genetics phospholipase AZ (PLA2)
dc.subject.eng.fl_str_mv	biochemistry enzymology genetics phospholipase AZ (PLA2)
publishDate	2009
dc.date.accessioned.none.fl_str_mv	2009-12-01 00:00:00 2022-02-21T20:37:37Z
dc.date.issued.none.fl_str_mv	2009-12-01
dc.date.available.none.fl_str_mv	2009-12-01 00:00:00 2022-02-21T20:37:37Z
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.eng.fl_str_mv	Journal article
dc.type.coar.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_6501
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.content.spa.fl_str_mv	Text
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_6501
status_str	publishedVersion
dc.identifier.doi.none.fl_str_mv	10.31260/RepertMedCir.v18.n4.2009.555
dc.identifier.issn.none.fl_str_mv	0121-7372
dc.identifier.uri.none.fl_str_mv	https://repositorio.fucsalud.edu.co/handle/001/2449
dc.identifier.eissn.none.fl_str_mv	2462-991X
dc.identifier.url.none.fl_str_mv	https://doi.org/10.31260/RepertMedCir.v18.n4.2009.555
identifier_str_mv	10.31260/RepertMedCir.v18.n4.2009.555 0121-7372 2462-991X
url	https://repositorio.fucsalud.edu.co/handle/001/2449 https://doi.org/10.31260/RepertMedCir.v18.n4.2009.555
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	García GA, Gaitán AA, García Cardona A, Clavijo D, Mejía ÓR, Cobos Claudia et al. Aspectos biomédicos de las fosfolipasas A2 en la especie humana. Med UNAB. 2008; 11(1): 14-27. IUPAC, IUBMB, [BASE DE DATOS EN INTERNET]. LONDON: INTERNATIONAL UNION OF BIOCHEMISTRY AND MOLECULAR BIOLOGY; 1977, [FECHA DE ACCESO 20 DE ABRIL DEL 2009]. DISPONIBLE EN: http://www.chem.qmul.ac.uk/iupac/jcbn/index.html#2. OMIM [base de datos en Internet]. Baltimore: Johns Hopkins University; 1966, [fecha de acceso 20 de abril del 2009]. Disponible en: http://www.ncbi.nlm.nih.gov/entrez/dispomim. HUGO [base de datos en Internet]. Bethesda: National Library of Medicine and others (exp.: Celera Genomics and the Sanger Center); 1989, [fecha de acceso 20 de abril del 2009]. Disponible en: http://www.hugo-international.org/index.html. Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta. 2006; 1761(11): 1246-59. Ghosh M, Tucker DE, Burchett SA, Leslie CC. Properties of the Group IV phospholipase A2 family. Prog Lipid Res. 2006; 45(6): 487-10. Shimizu T, Ohto T, Kita Y. Cytosolic phospholipase A2: biochemical properties and physiological roles. IUBMB Life. 2006; 58(5-6): 328-33. Grewal S, Herbert SP, Ponnambalam S, Walker JH. Cytosolic phospholipase A2-alpha and cyclooxygenase-2 localize to intracellular membranes of EA.hy.926 endothelial cells that are distinct from the endoplasmic reticulum and the Golgi apparatus. FEBS J. 2005; 272(5): 1278-90. Bailleux A, Wendum D, Audubert F, Jouniaux AM, Koumanov K, Trugnan G et al. Cytosolic phospholipase A2-p11 interaction controls arachidonic acid release as a function of epithelial cell confluence. Biochem J. 2004; 378(Pt 2): 307-15. Parente L, Solito E. Annexin 1: more than an anti-phospholipase protein. Inflamm Res. 2004; 53(4): 125-32. Sheridan AM, Force T, Yoon HJ, O Leary E, Choukroun G, Taheri MR et al. PLIP, a novel splice variant of Tip60, interacts with group IV cytosolic phospholipase A(2), induces apoptosis, and potentiates prostaglandin production. Mol Cell Biol. 2001; 21(14): 4470-81. Mariggiò S, Bavec A, Natale E, Zizza P, Salmona M, Corda D et al. Galpha13 mediates activation of the cytosolic phospholipase A2alpha through fine regulation of ERK phosphorylation. Cell Signal. 2006; 18(12): 2200-08. Mosavi LK, Cammett TJ, Desrosiers DC, Peng ZY. The ankyrin repeat as molecular architecture for protein recognition. Protein Sci. 2004; 13(6): 1435-48. Li J, Mahajan A, Tsai MD. Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry. 2006; 45(51): 15168-78. Akiba S, Sato T. Cellular function of calcium-independent phospholipase A2. Biol Pharm Bull. 2004; 27(8): 1174-78. Murakami M, Kudo I. Secretory phospholipase A2. Biol Pharm Bull. 2004; 27(8): 1158-1164. Fransson LA. Glypicans. Int J Biochem Cell Biol. 2003; 35(2): 125-29. Fransson LA, Belting M, Cheng F, Jönsson M, Mani K, Sandgren S. Novel aspects of glypican glycobiology. Cell Mol Life Sci. 2004; 61(6): 1016-24. Arai H. Platelet-activating factor acetylhydrolase. Prostaglandins Other Lipid Mediat. 2002; 68-69: 83-94. Karasawa K, Harada A, Satoh N, Inoue K, Setaka M. Plasma platelet activating factor-acetylhydrolase (PAF-AH). Prog Lipid Res. 2003; 42(2): 93-14. Cook JA. Eicosanoids. Crit Care Med. 2005; 33(12 Suppl): S488-91. Khanapure SP, Garvey DS, Janero DR, Letts LG. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem. 2007; 7(3): 311-40. Chiang N, Serhan CN. Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators. Methods Mol Biol. 2006; 341: 227-50. Serhan CN. Novel chemical mediators in the resolution of inflammation: resolvins and protectins. Anesthesiol Clin. 2006; 24(2): 341-64. Kuhn H, O Donnell VB. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res. 2006; 45(4): 334-56. Smita K, Sushil Kumar V, Premendran JS. Anandamide: an update. Fundam Clin Pharmacol 2007; 21(1): 1-8. Stafforini DM, McIntyre TM, Zimmerman, GA Prescott SM. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci. 2003; 40(6): 643-72. Spector AA, Fang X, Snyder GD, Weintraub NL. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res. 2004; 43(1): 55-90. Elbekai RH, El-Kadi AO. Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacol Ther. 2006; 112(2): 564-87. Van Der Stelt M, Di Marzo V. Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur J Biochem. 2004; 271(10): 1827-34. Montuschi P, Barnes P, Roberts LJ 2nd. Insights into oxidative stress: the isoprostanes. Curr Med Chem. 2007; 14(6): 703-17. Milligan G, Stoddart LA, Brown AJ. G protein-coupled receptors for free fatty acids. Cell Signal. 2006; 18(9): 1360-65. Kostadinova R, Wahli W, Michalik L. PPARs in diseases: control mechanisms of inflammation. Curr Med Chem. 2005; 12(25): 2995-09. Burke JE, Dennis EA. Phospholipase A2 biochemistry. Cardiovasc Drugs Ther. 2009; 23(1): 49-59. Veenman L, Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ther. 2006; 110(3): 503-24. Muller CA, Autenrieth IB, Peschel A. Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci. 2005; 62(12): 1297-1307. Keshav S. Paneth cells: leukocyte-like mediators of innate immunity in the intestine. J Leukoc Biol. 2006; 80(3): 500-08. Beers SA, Buckland AG, Koduri RS, Cho W, Gelb MH, Wilton DC. The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J Biol Chem. 2002; 277(3): 1788-93. Nevalainen TJ, Graham GG, Scott KF. Antibacterial actions of secreted phospholipases A2. Biochim Biophys Acta. 2008; 1781(1- 2): 1-9. Diaz BL, Satake Y, Kikawada E, Balestrieri B, Arm JP. Group V secretory phospholipase A2 amplifies the induction of cyclooxygenase 2 and delayed prostaglandin D2 generation in mouse bone marrow culture-derived mast cells in a strain-dependent manner. Biochim Biophys Acta. 2006; 1761(12): 1489-97. Satake Y, Diaz BL, Balestrieri B, Lam BK, Kanaoka Y, Grusby MJ et al. Role of group V phospholipase A2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. J Biol Chem. 2004; 279(16): 16488-94. Mitsuishi M, Masuda S, Kudo I, Murakami M. Group V and X secretory phospholipase A2 prevents adenoviral infection in mammalian cells. Biochem J. 2006; 393(Pt1): 97-106. Kim JO, Chakrabarti BK, Guha-Niyogi A, Louder MK, Mascola JR, Ganesh L, et al. Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2. J Virol. 2007; 810028(3): 1444-50. Zhu J, Massey JB, Mitchell-Leef D, Elsner CW, Kort HI, Roudebush WE. Platelet-activating factor acetylhydrolase activity affects sperm motility and serves as a decapacitation factor. Fertil Steril. 2006; 85(2): 391-94. Wang H, Xie H, Dey SK. Endocannabinoid signaling directs periimplantation events. AAPS J. 2006(2); 8: E425-432. Lappas M, Rice GE. Phospholipase A2 isozymes in pregnancy and parturition. Prostaglandins Leukot Essent Fatty Acids. 2004; 70(2): 87-100. Burke JR. Targeting phospholipase A2 for the treatment of inflammatory skin diseases. Curr Opin Investig Drugs. 2001; 2(11): 1549-1552. Maury E, Julié S, Charvéron M, Gall Y, Chap H. Lipids and skin inflammation: role of phospholipases A2. Pathol Biol (Paris). 2003; 51(5): 248-52. Whitcomb DC, Lowe ME. Human pancreatic digestive enzymes. Dig Dis Sci 2007; 52(1): 1-17. Touqui L, Wu YZ. Interaction of secreted phospholipase A2 and pulmonary surfactant and its pathophysiological relevance in acute respiratory distress syndrome. Acta Pharmacol Sin 2003; 24(12): 1292-96. Mounier CM, Bon C, Kini RM. Anticoagulant venom and mammalian secreted phospholipases A(2): protein- versus phospholipid-dependent mechanism of action. Haemostasis. 2001; 31(3-6): 279-87. Kini RM. Anticoagulant proteins from snake venoms: structure, function and mechanism. Biochem J. 2006; 397: 377-87. Matsuzawa A, Hattori K, Aoki J, Arai H, Inoue K. Protection against oxidative stress-induced cell death by intracellular plateletactivating factor-acetylhydrolase II. J Biol Chem. 1997; 272(51): 32315-20. Marques M, Pei Y, Southall MD, Johnston JM, Arai H, Aoki J, et al. Identification of platelet-activating factor acetylhydrolase II in human skin. J Invest Dermatol. 2002; 119: 913-9. Smani T, Zakharov SI, Leno E, Csutora P, Trepakova ES, Bolotina VM. Ca2+-independent phospholipase A2 is a novel determinant of store-operated Ca2+ entry. J Biol Chem. 2003; 278(14): 11909-15. Smani T, Zakharov SI, Csutora P, Leno E, Trepakova ES, Bolotina VM. A novel mechanism for the store-operated calcium influx pathway. Nat Cell Biol. 2004; 6: 113-20. Bolotina VM, Csutora P. CIF and other mysteries of the storeoperated Ca2+-entry pathway. Trends Biochem Sci. 2005; 30: 378-87. Cheng KT, Liu X, Ong HL, Ambudkar IS. Functional requirement for Orai1 in store-operated TRPC1-STIM1 channels. J Biol Chem. 2008; 283(19): 12935-40. Balsinde J, Balboa MA. Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells. Cell Signal. 2005; 17: 1052-62. Yang J, Han X, Gross RW. Identification of hepatic peroxisomal phospholipase A(2) and characterization of arachidonic acidcontaining choline glycerophospholipids in hepatic peroxisomes. FEBS Lett. 2003; 546: 247-50. Peterson B, Knotts T, Cummings BS. Involvement of Ca2+-independent phospholipase A2 isoforms in oxidant-induced neural cell death. Neurotoxicology. 2007; 28: 150-60. Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr. 2007; 27: 79-101. Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am J Physiol Gastrointest Liver Physiol. 2007; 293: G1-4.
dc.relation.bitstream.none.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/555/595
dc.relation.citationedition.spa.fl_str_mv	Núm. 4 , Año 2009 : Octubre - Diciembre
dc.relation.citationendpage.none.fl_str_mv	209
dc.relation.citationissue.spa.fl_str_mv	4
dc.relation.citationstartpage.none.fl_str_mv	199
dc.relation.citationvolume.spa.fl_str_mv	18
dc.relation.ispartofjournal.spa.fl_str_mv	Revista Repertorio de Medicina y Cirugía
dc.rights.spa.fl_str_mv	Fundación Universitaria de Ciencias de la Salud FUCS - 0
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by-nc-sa/4.0/
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Fundación Universitaria de Ciencias de la Salud FUCS - 0 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud
dc.source.spa.fl_str_mv	https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/555
institution	Fundación Universitaria de Ciencias de la Salud - FUCS
bitstream.url.fl_str_mv	https://repositorio.fucsalud.edu.co/bitstreams/c20c37fd-2e77-4856-bf28-7a75fe7ec074/download
bitstream.checksum.fl_str_mv	300da192d0e20c042517399899d2b336
bitstream.checksumAlgorithm.fl_str_mv	MD5
repository.name.fl_str_mv	Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud
repository.mail.fl_str_mv	redi@fucsalud.edu.co
_version_	1814355563406950400
spelling	García, Gregory Alfonso740be0b34aed4c885a4243a3659ae6b7500García Cardona, Ananíasa8cc134415becd070bde2a9d0becc0be5002009-12-01 00:00:002022-02-21T20:37:37Z2009-12-012009-12-01 00:00:002022-02-21T20:37:37ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud FUCS - 0info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/555bioquímicoenzimologíagenéticafosfolipasa AZ (PLA2)biochemistryenzymologygeneticsphospholipase AZ (PLA2)Fosfolipasas A2: Grandes familias y mecanismos de acciónPhospholipases A2: Large families and mechanisms of actionapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v18.n4.2009.5550121-7372https://repositorio.fucsalud.edu.co/handle/001/24492462-991Xhttps://doi.org/10.31260/RepertMedCir.v18.n4.2009.555spaGarcía GA, Gaitán AA, García Cardona A, Clavijo D, Mejía ÓR, Cobos Claudia et al. Aspectos biomédicos de las fosfolipasas A2 en la especie humana. Med UNAB. 2008; 11(1): 14-27.IUPAC, IUBMB, [BASE DE DATOS EN INTERNET]. LONDON: INTERNATIONAL UNION OF BIOCHEMISTRY AND MOLECULAR BIOLOGY; 1977, [FECHA DE ACCESO 20 DE ABRIL DEL 2009]. DISPONIBLE EN: http://www.chem.qmul.ac.uk/iupac/jcbn/index.html#2.OMIM [base de datos en Internet]. Baltimore: Johns Hopkins University; 1966, [fecha de acceso 20 de abril del 2009]. Disponible en: http://www.ncbi.nlm.nih.gov/entrez/dispomim.HUGO [base de datos en Internet]. Bethesda: National Library of Medicine and others (exp.: Celera Genomics and the Sanger Center); 1989, [fecha de acceso 20 de abril del 2009]. Disponible en: http://www.hugo-international.org/index.html.Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta. 2006; 1761(11): 1246-59.Ghosh M, Tucker DE, Burchett SA, Leslie CC. Properties of the Group IV phospholipase A2 family. Prog Lipid Res. 2006; 45(6): 487-10.Shimizu T, Ohto T, Kita Y. Cytosolic phospholipase A2: biochemical properties and physiological roles. IUBMB Life. 2006; 58(5-6): 328-33.Grewal S, Herbert SP, Ponnambalam S, Walker JH. Cytosolic phospholipase A2-alpha and cyclooxygenase-2 localize to intracellular membranes of EA.hy.926 endothelial cells that are distinct from the endoplasmic reticulum and the Golgi apparatus. FEBS J. 2005; 272(5): 1278-90.Bailleux A, Wendum D, Audubert F, Jouniaux AM, Koumanov K, Trugnan G et al. Cytosolic phospholipase A2-p11 interaction controls arachidonic acid release as a function of epithelial cell confluence. Biochem J. 2004; 378(Pt 2): 307-15.Parente L, Solito E. Annexin 1: more than an anti-phospholipase protein. Inflamm Res. 2004; 53(4): 125-32.Sheridan AM, Force T, Yoon HJ, O Leary E, Choukroun G, Taheri MR et al. PLIP, a novel splice variant of Tip60, interacts with group IV cytosolic phospholipase A(2), induces apoptosis, and potentiates prostaglandin production. Mol Cell Biol. 2001; 21(14): 4470-81.Mariggiò S, Bavec A, Natale E, Zizza P, Salmona M, Corda D et al. Galpha13 mediates activation of the cytosolic phospholipase A2alpha through fine regulation of ERK phosphorylation. Cell Signal. 2006; 18(12): 2200-08.Mosavi LK, Cammett TJ, Desrosiers DC, Peng ZY. The ankyrin repeat as molecular architecture for protein recognition. Protein Sci. 2004; 13(6): 1435-48.Li J, Mahajan A, Tsai MD. Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry. 2006; 45(51): 15168-78.Akiba S, Sato T. Cellular function of calcium-independent phospholipase A2. Biol Pharm Bull. 2004; 27(8): 1174-78.Murakami M, Kudo I. Secretory phospholipase A2. Biol Pharm Bull. 2004; 27(8): 1158-1164.Fransson LA. Glypicans. Int J Biochem Cell Biol. 2003; 35(2): 125-29.Fransson LA, Belting M, Cheng F, Jönsson M, Mani K, Sandgren S. Novel aspects of glypican glycobiology. Cell Mol Life Sci. 2004; 61(6): 1016-24.Arai H. Platelet-activating factor acetylhydrolase. Prostaglandins Other Lipid Mediat. 2002; 68-69: 83-94.Karasawa K, Harada A, Satoh N, Inoue K, Setaka M. Plasma platelet activating factor-acetylhydrolase (PAF-AH). Prog Lipid Res. 2003; 42(2): 93-14.Cook JA. Eicosanoids. Crit Care Med. 2005; 33(12 Suppl): S488-91.Khanapure SP, Garvey DS, Janero DR, Letts LG. Eicosanoids in inflammation: biosynthesis, pharmacology, and therapeutic frontiers. Curr Top Med Chem. 2007; 7(3): 311-40.Chiang N, Serhan CN. Cell-cell interaction in the transcellular biosynthesis of novel omega-3-derived lipid mediators. Methods Mol Biol. 2006; 341: 227-50.Serhan CN. Novel chemical mediators in the resolution of inflammation: resolvins and protectins. Anesthesiol Clin. 2006; 24(2): 341-64.Kuhn H, O Donnell VB. Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res. 2006; 45(4): 334-56.Smita K, Sushil Kumar V, Premendran JS. Anandamide: an update. Fundam Clin Pharmacol 2007; 21(1): 1-8.Stafforini DM, McIntyre TM, Zimmerman, GA Prescott SM. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci. 2003; 40(6): 643-72.Spector AA, Fang X, Snyder GD, Weintraub NL. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res. 2004; 43(1): 55-90.Elbekai RH, El-Kadi AO. Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacol Ther. 2006; 112(2): 564-87.Van Der Stelt M, Di Marzo V. Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels. Eur J Biochem. 2004; 271(10): 1827-34.Montuschi P, Barnes P, Roberts LJ 2nd. Insights into oxidative stress: the isoprostanes. Curr Med Chem. 2007; 14(6): 703-17.Milligan G, Stoddart LA, Brown AJ. G protein-coupled receptors for free fatty acids. Cell Signal. 2006; 18(9): 1360-65.Kostadinova R, Wahli W, Michalik L. PPARs in diseases: control mechanisms of inflammation. Curr Med Chem. 2005; 12(25): 2995-09.Burke JE, Dennis EA. Phospholipase A2 biochemistry. Cardiovasc Drugs Ther. 2009; 23(1): 49-59.Veenman L, Gavish M. The peripheral-type benzodiazepine receptor and the cardiovascular system. Implications for drug development. Pharmacol Ther. 2006; 110(3): 503-24.Muller CA, Autenrieth IB, Peschel A. Innate defenses of the intestinal epithelial barrier. Cell Mol Life Sci. 2005; 62(12): 1297-1307.Keshav S. Paneth cells: leukocyte-like mediators of innate immunity in the intestine. J Leukoc Biol. 2006; 80(3): 500-08.Beers SA, Buckland AG, Koduri RS, Cho W, Gelb MH, Wilton DC. The antibacterial properties of secreted phospholipases A2: a major physiological role for the group IIA enzyme that depends on the very high pI of the enzyme to allow penetration of the bacterial cell wall. J Biol Chem. 2002; 277(3): 1788-93.Nevalainen TJ, Graham GG, Scott KF. Antibacterial actions of secreted phospholipases A2. Biochim Biophys Acta. 2008; 1781(1- 2): 1-9.Diaz BL, Satake Y, Kikawada E, Balestrieri B, Arm JP. Group V secretory phospholipase A2 amplifies the induction of cyclooxygenase 2 and delayed prostaglandin D2 generation in mouse bone marrow culture-derived mast cells in a strain-dependent manner. Biochim Biophys Acta. 2006; 1761(12): 1489-97.Satake Y, Diaz BL, Balestrieri B, Lam BK, Kanaoka Y, Grusby MJ et al. Role of group V phospholipase A2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. J Biol Chem. 2004; 279(16): 16488-94.Mitsuishi M, Masuda S, Kudo I, Murakami M. Group V and X secretory phospholipase A2 prevents adenoviral infection in mammalian cells. Biochem J. 2006; 393(Pt1): 97-106.Kim JO, Chakrabarti BK, Guha-Niyogi A, Louder MK, Mascola JR, Ganesh L, et al. Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase A2. J Virol. 2007; 810028(3): 1444-50.Zhu J, Massey JB, Mitchell-Leef D, Elsner CW, Kort HI, Roudebush WE. Platelet-activating factor acetylhydrolase activity affects sperm motility and serves as a decapacitation factor. Fertil Steril. 2006; 85(2): 391-94.Wang H, Xie H, Dey SK. Endocannabinoid signaling directs periimplantation events. AAPS J. 2006(2); 8: E425-432.Lappas M, Rice GE. Phospholipase A2 isozymes in pregnancy and parturition. Prostaglandins Leukot Essent Fatty Acids. 2004; 70(2): 87-100.Burke JR. Targeting phospholipase A2 for the treatment of inflammatory skin diseases. Curr Opin Investig Drugs. 2001; 2(11): 1549-1552.Maury E, Julié S, Charvéron M, Gall Y, Chap H. Lipids and skin inflammation: role of phospholipases A2. Pathol Biol (Paris). 2003; 51(5): 248-52.Whitcomb DC, Lowe ME. Human pancreatic digestive enzymes. Dig Dis Sci 2007; 52(1): 1-17.Touqui L, Wu YZ. Interaction of secreted phospholipase A2 and pulmonary surfactant and its pathophysiological relevance in acute respiratory distress syndrome. Acta Pharmacol Sin 2003; 24(12): 1292-96.Mounier CM, Bon C, Kini RM. Anticoagulant venom and mammalian secreted phospholipases A(2): protein- versus phospholipid-dependent mechanism of action. Haemostasis. 2001; 31(3-6): 279-87.Kini RM. Anticoagulant proteins from snake venoms: structure, function and mechanism. Biochem J. 2006; 397: 377-87.Matsuzawa A, Hattori K, Aoki J, Arai H, Inoue K. Protection against oxidative stress-induced cell death by intracellular plateletactivating factor-acetylhydrolase II. J Biol Chem. 1997; 272(51): 32315-20.Marques M, Pei Y, Southall MD, Johnston JM, Arai H, Aoki J, et al. Identification of platelet-activating factor acetylhydrolase II in human skin. J Invest Dermatol. 2002; 119: 913-9.Smani T, Zakharov SI, Leno E, Csutora P, Trepakova ES, Bolotina VM. Ca2+-independent phospholipase A2 is a novel determinant of store-operated Ca2+ entry. J Biol Chem. 2003; 278(14): 11909-15.Smani T, Zakharov SI, Csutora P, Leno E, Trepakova ES, Bolotina VM. A novel mechanism for the store-operated calcium influx pathway. Nat Cell Biol. 2004; 6: 113-20.Bolotina VM, Csutora P. CIF and other mysteries of the storeoperated Ca2+-entry pathway. Trends Biochem Sci. 2005; 30: 378-87.Cheng KT, Liu X, Ong HL, Ambudkar IS. Functional requirement for Orai1 in store-operated TRPC1-STIM1 channels. J Biol Chem. 2008; 283(19): 12935-40.Balsinde J, Balboa MA. Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells. Cell Signal. 2005; 17: 1052-62.Yang J, Han X, Gross RW. Identification of hepatic peroxisomal phospholipase A(2) and characterization of arachidonic acidcontaining choline glycerophospholipids in hepatic peroxisomes. FEBS Lett. 2003; 546: 247-50.Peterson B, Knotts T, Cummings BS. Involvement of Ca2+-independent phospholipase A2 isoforms in oxidant-induced neural cell death. Neurotoxicology. 2007; 28: 150-60.Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr. 2007; 27: 79-101.Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am J Physiol Gastrointest Liver Physiol. 2007; 293: G1-4.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/555/595Núm. 4 , Año 2009 : Octubre - Diciembre209419918Revista Repertorio de Medicina y CirugíaPublicationOREORE.xmltext/xml2491https://repositorio.fucsalud.edu.co/bitstreams/c20c37fd-2e77-4856-bf28-7a75fe7ec074/download300da192d0e20c042517399899d2b336MD51001/2449oai:repositorio.fucsalud.edu.co:001/24492024-02-02 13:10:42.018https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud FUCS - 0metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co

Fosfolipasas A2: Grandes familias y mecanismos de acción

Publicaciones similares